During the past decade, iResearch Atlanta LLC conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 51 clinical trials were completed, i.e. on average, 48.1% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 43 clinical trials were completed. i.e. 74.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "iResearch Atlanta LLC" #1 sponsor was "Sunovion" with 10 trials, followed by "Allergan" with 8 trials sponsored, "Pfizer" with 7 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 6 trials sponsored and "ModernaTX, Inc." with 6 trials sponsored. Other sponsors include 75 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "iResearch Atlanta LLC" #1 collaborator was "National Institute on Aging (NIA)" with 4 trials as a collaborator, "H. Lundbeck A/S" with 2 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "iResearch Atlanta LLC" are "Schizophrenia" (12 trials), "Alzheimer Disease" (11 trials), "Alzheimer's Disease" (9 trials), "Depressive Disorder, Major" (9 trials) and "Migraine" (5 trials). Many other conditions were trialed in "iResearch Atlanta LLC" in a lesser frequency.

Most popular intervention types in "iResearch Atlanta LLC" are "Drug" (107 trials), "Biological" (9 trials), "Other" (7 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (74 trials), "Rapastinel" (6 trials), "ATH-1017" (4 trials), "Dasotraline" (4 trials) and "Donepezil" (4 trials). Other intervention names were less common.

The vast majority of trials in "iResearch Atlanta LLC" are 110 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "iResearch Atlanta LLC". undefined are not yet recruiting, 20 are recruiting, 11 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 71 completed trials in iResearch Atlanta LLC, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in iResearch Atlanta LLC, 7 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".